Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications.
作者信息
Dixit Anjali A, Bateman Brian T, Hawn Mary T, Odden Michelle C, Sun Eric C
机构信息
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Department of Surgery, Stanford University School of Medicine, Stanford, California.
出版信息
JAMA. 2024 May 21;331(19):1672-1673. doi: 10.1001/jama.2024.5003.
Abstract
摘要
相似文献
1
Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications.
JAMA. 2024 May 21;331(19):1672-1673. doi: 10.1001/jama.2024.5003.
2
Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
JAMA. 2024 Jul 9;332(2):171. doi: 10.1001/jama.2024.10023.
3
Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
JAMA. 2024 Jul 9;332(2):171-172. doi: 10.1001/jama.2024.10026.
4
Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
JAMA. 2024 Jul 9;332(2):170-171. doi: 10.1001/jama.2024.10029.
5
First Large Study of GLP-1 Receptor Agonists During Pregnancy.
JAMA. 2024 Jan 23;331(4):280. doi: 10.1001/jama.2023.26112.
6
Diabetic Kidney Disease - Semaglutide Flows into the Mainstream.
N Engl J Med. 2024 Jul 11;391(2):178-179. doi: 10.1056/NEJMe2406408.
7
Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications-Reply.
JAMA. 2024 Jul 9;332(2):172-173. doi: 10.1001/jama.2024.10032.
8
Delivery Device Patents on GLP-1 Receptor Agonists.
JAMA. 2024 Mar 5;331(9):794-796. doi: 10.1001/jama.2024.0919.
9
Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists.
Diabetes Obes Metab. 2024 Aug;26(8):3128-3136. doi: 10.1111/dom.15636. Epub 2024 May 14.
10
Cardiovascular and diabetes outcomes among patients with obesity and type 2 diabetes after metabolic bariatric surgery or glucagon-like peptide 1 receptor agonist treatment.
Br J Surg. 2024 Aug 30;111(9). doi: 10.1093/bjs/znae221.
引用本文的文献
1
Glucagon-Like Peptide-1 Receptor Agonists and Peri-Procedural Aspiration Risk.
J Endocr Soc. 2025 Jul 10;9(9):bvaf088. doi: 10.1210/jendso/bvaf088. eCollection 2025 Sep.
2
Impact of Glucagon-Like Peptide-1 Receptor Agonist Exposure on Gastrointestinal Outcomes Among ICU Patients: A Multicenter Matched Cohort Study.
Crit Care Explor. 2025 May 14;7(5):e1263. doi: 10.1097/CCE.0000000000001263. eCollection 2025 May 1.
3
Glucagon-like-peptide-1 (GLP-1) receptor agonist use and the risk of pulmonary aspiration in patients undergoing surgery.
Int J Surg. 2025 Jun 1;111(6):4090-4093. doi: 10.1097/JS9.0000000000002425. Epub 2025 May 12.
4
Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy - a retrospective cohort study.
BMJ Open Gastroenterol. 2025 Apr 2;12(1):e001704. doi: 10.1136/bmjgast-2024-001704.
5
A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia.
J Anesth Analg Crit Care. 2025 Mar 28;5(1):16. doi: 10.1186/s44158-025-00237-y.
6
Exogenous oral application of PYY and exendin-4 impacts upon taste-related behavior and taste perception in wild-type mice.
Neuropharmacology. 2025 Jul 1;272:110408. doi: 10.1016/j.neuropharm.2025.110408. Epub 2025 Mar 12.
7
Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists.
JAMA Netw Open. 2025 Mar 3;8(3):e250081. doi: 10.1001/jamanetworkopen.2025.0081.
8
Preoperative SGLT2 Inhibitor Use and Postoperative Diabetic Ketoacidosis.
JAMA Surg. 2025 Apr 1;160(4):423-430. doi: 10.1001/jamasurg.2024.7082.
9
GLP-1 receptor agonist use does not increase risk of respiratory complications post-endoscopy.
Endosc Int Open. 2025 Jan 13;13:a24872937. doi: 10.1055/a-2487-2937. eCollection 2025.
10
Mapping the effectiveness and risks of GLP-1 receptor agonists.
Nat Med. 2025 Mar;31(3):951-962. doi: 10.1038/s41591-024-03412-w. Epub 2025 Jan 20.
Zotero 插件